Nayara closed an undisclosed pre seed round led by SFC Capital. The London health technology company develops AI companions that answer routine questions, check in with patients between appointments and route concerns to clinical teams. Cofounders Gal Moore and Rami Kahan have focused initial work on hospitals, health systems and medical technology companies. The company says its platform is already used in oncology pathways, including support for breast cancer patients, but those usage statements remain company reported. The financing will support product development, clinical validation and commercial expansion. No amount was disclosed, and the image and readiness package remain subject to separate review.
Nayara closes pre seed financing for patient support
SFC Capital leads the undisclosed round

Keep reading
More Funding

BrightAI secures USD 97 million to scale physical AI infrastructure
Smith Point Capital led the investment in sensor based monitoring for essential services.

Dcubed raises EUR 27.2 million to expand space hardware production
Warsaw Equity Group led the oversubscribed Series A plus round for the German manufacturer.

Linq raises USD 90 million to expand AI powered mobile infrastructure
Andreessen Horowitz led the Series B and partner Ben Horowitz joined the board.


